Presentation NY Valves 2024 The Trilogy TAVR System and an Update on the ALIGN-AR Study Presenter: Raj Makkar June 05, 2024
Presentation NY Valves 2024 Hemodynamic Performance and Restoration of Laminar Flow Presenter: Michael J. Reardon June 05, 2024
Presentation NY Valves 2024 Options for a Lifetime and Long-Term Durability Presenter: Ole De Backer June 05, 2024
Presentation NY Valves 2024 Innovation in TAVR for Pure AR (J Valve) Presenter: Tsuyoshi Kaneko June 05, 2024
Presentation NY Valves 2024 Clinical Results with the DurAVR THV System Presenter: Susheel K. Kodali June 05, 2024
Presentation NY Valves 2024 Is Underdiagnosis of AR a Real Problem? Imaging Methods for the Evaluation of Aortic Regurgitation Presenter: Vera Rigolin June 05, 2024
Presentation NY Valves 2024 Understanding the Fundamentals of the ACURATE Platform Presenter: Isaac George June 05, 2024
Presentation NY Valves 2024 A New Class of TAVR, A New Design Target Presenter: Christopher Meduri June 05, 2024
Presentation NY Valves 2024 Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials Presenter: Rebecca T. Hahn June 05, 2024
Presentation NY Valves 2024 Impact of Cerebral Embolic Protection Devices on Disabling Stroke After Transcatheter Aortic Valve Replacement: Results From the STS/ACC TVT Registry Presenter: Neel Butala June 05, 2024
Presentation NY Valves 2024 Predictors of Bioprosthetic Valve Dysfunction From the Randomized SMART Trial Presenter: Howard C. Herrmann June 05, 2024
Presentation NY Valves 2024 A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial Presenter: Ole De Backer June 05, 2024
Presentation NY Valves 2024 Transcatheter Aortic Valve Replacement Among Patients Receiving Renal Dialysis Presenter: Chloe Kharsa June 05, 2024
Presentation NY Valves 2024 Impact of Pulmonary Hypertension on Transcatheter Aortic Valve Replacement Outcomes: A Large Cohort Analysis Presenter: Samarthkumar Thakkar June 05, 2024
Presentation NY Valves 2024 Chronic Kidney Disease and In-hospital Outcomes in TAVR Patients Presenter: Sabina Kumar June 05, 2024
Presentation NY Valves 2024 Impact of Surgical or Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis on Perioperative Outcomes in Patients Undergoing Noncardiac Surgery Presenter: Kitae Kim June 05, 2024
Presentation NY Valves 2024 Renin-Angiotensin System Inhibition in Patients With Myocardial Injury Complicating Transcatheter Aortic Valve Replacement Presenter: Daijiro Tomii June 05, 2024
Presentation NY Valves 2024 Pre-Existing Thoracic Aortic Aneurysm is Associated with Type A Aortic Dissections After Transcatheter Aortic Valve Replacement Presenter: Tyler Bauer June 05, 2024
Presentation NY Valves 2024 Impact of Atherosclerotic Disease Extent on Clinical Outcomes in Female Patients Undergoing TAVI: A Report From the WIN-TAVI Registry Presenter: Benjamin Bay June 05, 2024
Presentation NY Valves 2024 3 Reasons Why… TAVR First Is the Best Option! Presenter: Mayra Guerrero June 05, 2024